Operative Strategies to Minimize Complications Following Resection of Pituitary Macroadenomas

Abstract

Introduction We sought to identify factors associated with increased length of stay (LOS) and morbidity in patients undergoing resection of pituitary macroadenomas.

Methods We reviewed records of 203 consecutive patients who underwent endoscopic endonasal resection of a pituitary macroadenoma (mean age = 55.7 [16–88]) years, volume = 11.3 (1.0–134.3) cm³. Complete resection was possible in 60/29.6% patients. Mean follow-up was 575 days. Multivariate logistic regression was performed using MATLAB.

Results Mean LOS was 4.67 (1–66) days and was associated with CSF leak (p = 0.025), lumbar drain placement (p = 0.041; n = 8/3.9% intraoperative, n = 20/9.9% postoperative), and any infection (p = 0.066). Age, diabetes insipidus (n = 17/8.37%), and syndrome of inappropriate antidiuretic hormone secretion (n = 12/5.9%) were not associated with increased LOS (p > 0.2). Postoperative CSF leak in the hospital (n = 21/10.3%) was associated with intraoperative CSF leak (p = 0.002; n = 82/40.4%) and complete resection (p = 0.012). There was no significant association (p > 0.1) between postoperative CSF leak in the hospital following surgery and the use of a fat graft (n = 61/30.1%), nasoseptal flap (155/76.4%), or perioperative lumbar drain placement (n = 8/3.94%).

Conclusion Complete resection is associated with increased risk of CSF leak and LOS. Operative strategies including placement of fat graft, nasoseptal flap, or intraoperative lumbar drain placement may have limited value in reducing the risk of postoperative CSF leak.

Keywords

pituitary macroadenoma - length of stay

^* Denotes equal contribution

• References

• 1 Komotar RJ, Starke RM, Raper DMS, Anand VK, Schwartz TH. Endoscopic endonasal compared with microscopic transsphenoidal and open transcranial resection of giant pituitary adenomas. Pituitary 2012; 15 (2) 150-159 . http://www.ncbi.nlm.nih.gov/pubmed/22038033 . Accessed January 1, 2016
• 2 Goel A. Challenge of giant pituitary tumors. World Neurosurg 2014; 82: e121-e124 . http://www.ncbi.nlm.nih.gov/pubmed/24121298 . Accessed January 1, 2016
• 3 Gondim JA, Almeida JPC, Albuquerque LAF , et al. Endoscopic endonasal approach for pituitary adenoma: surgical complications in 301 patients. Pituitary 2011; 14 (2) 174-183
• 4 Hofstetter CP, Nanaszko MJ, Mubita LL, Tsiouris J, Anand VK, Schwartz TH. Volumetric classification of pituitary macroadenomas predicts outcome and morbidity following endoscopic endonasal transsphenoidal surgery. Pituitary 2012; 15 (3) 450-463
• 5 Gondim JA, Almeida JPC, Albuquerque LAF, Gomes EF, Schops M. Giant pituitary adenomas: surgical outcomes of 50 cases operated on by the endonasal endoscopic approach. World Neurosurg 2014; 82: e281-e290 . http://www.ncbi.nlm.nih.gov/pubmed/23994073 . Accessed January 1, 2016
• 6 Juraschka K, Khan OH, Godoy BL , et al. Endoscopic endonasal transsphenoidal approach to large and giant pituitary adenomas: institutional experience and predictors of extent of resection. J Neurosurg 2014; 121 (1) 75-83
• 7 Koutourousiou M, Gardner PA, Fernandez-Miranda JC, Paluzzi A, Wang EW, Snyderman CH. Endoscopic endonasal surgery for giant pituitary adenomas: advantages and limitations. J Neurosurg 2013; 118 (3) 621-631 . http://www.ncbi.nlm.nih.gov/pubmed/23289816 . Accessed January 1, 2016
• 8 Dallapiazza R, Bond AE, Grober Y , et al. Retrospective analysis of a concurrent series of microscopic versus endoscopic transsphenoidal surgeries for Knosp Grades 0-2 nonfunctioning pituitary macroadenomas at a single institution. J Neurosurg 2014; 121 (3) 511-517
• 9 Cavallo LM, Solari D, Tasiou A , et al. Endoscopic endonasal transsphenoidal removal of recurrent and regrowing pituitary adenomas: experience on a 59-patient series. World Neurosurg 2015; 80: 342-850 . http://www.ncbi.nlm.nih.gov/pubmed/23046913 . Accessed March 24, 2016
• 10 Chabot JD, Chakraborty S, Imbarrato G, Dehdashti AR. evaluation of outcomes after endoscopic endonasal surgery for large and giant pituitary macroadenoma: a retrospective review of 39 consecutive patients. World Neurosurg 2015; 84 (4) 978-988
• 11 Jahangiri A, Wagner J, Han SW , et al. Morbidity of repeat transsphenoidal surgery assessed in more than 1000 operations. J Neurosurg 2014; 121 (1) 67-74
• 12 Thomas JG, Gadgil N, Samson SL, Takashima M, Yoshor D. Prospective trial of a short hospital stay protocol after endoscopic endonasal pituitary adenoma surgery. World Neurosurg 2014; 81 (3–4): 576-583
• 13 Daudia A, Biswas D, Jones NS. Risk of meningitis with cerebrospinal fluid rhinorrhea. Ann Otol Rhinol Laryngol 2007; 116 (12) 902-905
• 14 Robert FSpetzler, Charles B. Wilson: management of recurrent CSF rhinorrhea of the middle and posterior fossa. 2009 http://thejns.org/doi/abs/10.3171/jns.1978.49.3.0393 . Accessed March 24, 2016
• 15 Finken MJJ, Zwaveling-Soonawala N, Walenkamp MJE, Vulsma T, van Trotsenburg ASP, Rotteveel J. Frequent occurrence of the triphasic response (diabetes insipidus/hyponatremia/diabetes insipidus) after surgery for craniopharyngioma in childhood. Horm Res Paediatr 2011; 76 (1) 22-26
• 16 DeKlotz TR, Chia SH, Lu W, Makambi KH, Aulisi E, Deeb Z. Meta-analysis of endoscopic versus sublabial pituitary surgery. Laryngoscope 2012; 122 (3) 511-518